Literature DB >> 35150638

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.

Alba Escalera1, Ana S Gonzalez-Reiche2, Sadaf Aslam3, Ignacio Mena3, Manon Laporte3, Rebecca L Pearl3, Andrea Fossati4, Raveen Rathnasinghe1, Hala Alshammary5, Adriana van de Guchte2, Keith Farrugia2, Yiren Qin6, Mehdi Bouhaddou4, Thomas Kehrer1, Lorena Zuliani-Alvarez4, David A Meekins7, Velmurugan Balaraman7, Chester McDowell7, Jürgen A Richt7, Goran Bajic5, Emilia Mia Sordillo8, Marion Dejosez6, Thomas P Zwaka6, Nevan J Krogan9, Viviana Simon10, Randy A Albrecht3, Harm van Bakel11, Adolfo García-Sastre12, Teresa Aydillo13.   

Abstract

SARS-CoV-2 lineages have diverged into highly prevalent variants termed "variants of concern" (VOCs). Here, we characterized emerging SARS-CoV-2 spike polymorphisms in vitro and in vivo to understand their impact on transmissibility and virus pathogenicity and fitness. We demonstrate that the substitution S:655Y, represented in the gamma and omicron VOCs, enhances viral replication and spike protein cleavage. The S:655Y substitution was transmitted more efficiently than its ancestor S:655H in the hamster infection model and was able to outcompete S:655H in the hamster model and in a human primary airway system. Finally, we analyzed a set of emerging SARS-CoV-2 variants to investigate how different sets of mutations may impact spike processing. All VOCs tested exhibited increased spike cleavage and fusogenic capacity. Taken together, our study demonstrates that the spike mutations present in VOCs that become epidemiologically prevalent in humans are linked to an increase in spike processing and virus transmission.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  H655Y mutation; SARS-CoV-2; fusion; gamma; omicron; spike cleavage; syncytia formation; variants of concern

Mesh:

Substances:

Year:  2022        PMID: 35150638      PMCID: PMC8776496          DOI: 10.1016/j.chom.2022.01.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   31.316


  52 in total

1.  Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.

Authors:  Brendan MacLean; Daniela M Tomazela; Nicholas Shulman; Matthew Chambers; Gregory L Finney; Barbara Frewen; Randall Kern; David L Tabb; Daniel C Liebler; Michael J MacCoss
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

2.  A new cell-based assay to evaluate myogenesis in mouse myoblast C2C12 cells.

Authors:  Manami Kodaka; Zeyu Yang; Kentaro Nakagawa; Junichi Maruyama; Xiaoyin Xu; Aradhan Sarkar; Ayana Ichimura; Yusuke Nasu; Takeaki Ozawa; Hiroaki Iwasa; Mari Ishigami-Yuasa; Shigeru Ito; Hiroyuki Kagechika; Yutaka Hata
Journal:  Exp Cell Res       Date:  2015-06-24       Impact factor: 3.905

3.  Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Authors:  Timothée Bruel; Etienne Simon-Lorière; Felix A Rey; Olivier Schwartz; Delphine Planas; David Veyer; Artem Baidaliuk; Isabelle Staropoli; Florence Guivel-Benhassine; Maaran Michael Rajah; Cyril Planchais; Françoise Porrot; Nicolas Robillard; Julien Puech; Matthieu Prot; Floriane Gallais; Pierre Gantner; Aurélie Velay; Julien Le Guen; Najiby Kassis-Chikhani; Dhiaeddine Edriss; Laurent Belec; Aymeric Seve; Laura Courtellemont; Hélène Péré; Laurent Hocqueloux; Samira Fafi-Kremer; Thierry Prazuck; Hugo Mouquet
Journal:  Nature       Date:  2021-07-08       Impact factor: 49.962

4.  Spike mutation D614G alters SARS-CoV-2 fitness.

Authors:  Jessica A Plante; Yang Liu; Jianying Liu; Hongjie Xia; Bryan A Johnson; Kumari G Lokugamage; Xianwen Zhang; Antonio E Muruato; Jing Zou; Camila R Fontes-Garfias; Divya Mirchandani; Dionna Scharton; John P Bilello; Zhiqiang Ku; Zhiqiang An; Birte Kalveram; Alexander N Freiberg; Vineet D Menachery; Xuping Xie; Kenneth S Plante; Scott C Weaver; Pei-Yong Shi
Journal:  Nature       Date:  2020-10-26       Impact factor: 49.962

5.  Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.

Authors:  Bryan A Johnson; Xuping Xie; Adam L Bailey; Birte Kalveram; Kumari G Lokugamage; Antonio Muruato; Jing Zou; Xianwen Zhang; Terry Juelich; Jennifer K Smith; Lihong Zhang; Nathen Bopp; Craig Schindewolf; Michelle Vu; Abigail Vanderheiden; Emma S Winkler; Daniele Swetnam; Jessica A Plante; Patricia Aguilar; Kenneth S Plante; Vsevolod Popov; Benhur Lee; Scott C Weaver; Mehul S Suthar; Andrew L Routh; Ping Ren; Zhiqiang Ku; Zhiqiang An; Kari Debbink; Michael S Diamond; Pei-Yong Shi; Alexander N Freiberg; Vineet D Menachery
Journal:  Nature       Date:  2021-01-25       Impact factor: 49.962

6.  MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics.

Authors:  Andy T Kong; Felipe V Leprevost; Dmitry M Avtonomov; Dattatreya Mellacheruvu; Alexey I Nesvizhskii
Journal:  Nat Methods       Date:  2017-04-10       Impact factor: 28.547

7.  Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.

Authors:  Kyle Rosenke; Kimberly Meade-White; Michael Letko; Chad Clancy; Frederick Hansen; Yanan Liu; Atsushi Okumura; Tsing-Lee Tang-Huau; Rong Li; Greg Saturday; Friederike Feldmann; Dana Scott; Zhongde Wang; Vincent Munster; Michael A Jarvis; Heinz Feldmann
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

8.  Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.

Authors:  Teresa Aydillo; Ana S Gonzalez-Reiche; Sadaf Aslam; Adriana van de Guchte; Zenab Khan; Ajay Obla; Jayeeta Dutta; Harm van Bakel; Judith Aberg; Adolfo García-Sastre; Gunjan Shah; Tobias Hohl; Genovefa Papanicolaou; Miguel-Angel Perales; Kent Sepkowitz; N Esther Babady; Mini Kamboj
Journal:  N Engl J Med       Date:  2020-12-01       Impact factor: 91.245

9.  Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.

Authors:  Jianzhong Shi; Zhiyuan Wen; Gongxun Zhong; Huanliang Yang; Chong Wang; Baoying Huang; Renqiang Liu; Xijun He; Lei Shuai; Ziruo Sun; Yubo Zhao; Peipei Liu; Libin Liang; Pengfei Cui; Jinliang Wang; Xianfeng Zhang; Yuntao Guan; Wenjie Tan; Guizhen Wu; Hualan Chen; Zhigao Bu
Journal:  Science       Date:  2020-04-08       Impact factor: 47.728

10.  Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.

Authors:  Shuvam Banerjee; Sohan Seal; Riju Dey; Kousik Kr Mondal; Pritha Bhattacharjee
Journal:  J Med Virol       Date:  2020-08-25       Impact factor: 20.693

View more
  30 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

2.  Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron.

Authors:  Choo Yee Yu; Sie Yeng Wong; Nancy Woan Charn Liew; Narcisse Joseph; Zunita Zakaria; Isa Nurulfiza; Hui Jen Soe; Rachna Kairon; Syafinaz Amin-Nordin; Hui Yee Chee
Journal:  Front Med (Lausanne)       Date:  2022-09-23

3.  Effect of inactivating RNA viruses by coupled UVC and UVA LEDs evaluated by a viral surrogate commonly used as a genetic vector.

Authors:  Yun Zhao; Jianfei Dong
Journal:  Biomed Opt Express       Date:  2022-07-28       Impact factor: 3.562

4.  An early warning system for emerging SARS-CoV-2 variants.

Authors:  Lorenzo Subissi; Anne von Gottberg; Lipi Thukral; Nathalie Worp; Bas B Oude Munnink; Surabhi Rathore; Laith J Abu-Raddad; Ximena Aguilera; Erik Alm; Brett N Archer; Homa Attar Cohen; Amal Barakat; Wendy S Barclay; Jinal N Bhiman; Leon Caly; Meera Chand; Mark Chen; Ann Cullinane; Tulio de Oliveira; Christian Drosten; Julian Druce; Paul Effler; Ihab El Masry; Adama Faye; Simani Gaseitsiwe; Elodie Ghedin; Rebecca Grant; Bart L Haagmans; Belinda L Herring; Shilpa S Iyer; Zyleen Kassamali; Manish Kakkar; Rebecca J Kondor; Juliana A Leite; Yee-Sin Leo; Gabriel M Leung; Marco Marklewitz; Sikhulile Moyo; Jairo Mendez-Rico; Nada M Melhem; Vincent Munster; Karen Nahapetyan; Djin-Ye Oh; Boris I Pavlin; Thomas P Peacock; Malik Peiris; Zhibin Peng; Leo L M Poon; Andrew Rambaut; Jilian Sacks; Yinzhong Shen; Marilda M Siqueira; Sofonias K Tessema; Erik M Volz; Volker Thiel; Sylvie van der Werf; Sylvie Briand; Mark D Perkins; Maria D Van Kerkhove; Marion P G Koopmans; Anurag Agrawal
Journal:  Nat Med       Date:  2022-06       Impact factor: 87.241

Review 5.  Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.

Authors:  Shuai Xia; Lijue Wang; Yun Zhu; Lu Lu; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2022-07-19

Review 6.  Antibody-mediated neutralization of SARS-CoV-2.

Authors:  Henning Gruell; Kanika Vanshylla; Timm Weber; Christopher O Barnes; Christoph Kreer; Florian Klein
Journal:  Immunity       Date:  2022-05-13       Impact factor: 43.474

7.  SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production.

Authors:  Zhujun Ao; Maggie Jing Ouyang; Titus Abiola Olukitibi; Xiaojian Yao
Journal:  iScience       Date:  2022-07-14

8.  Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.

Authors:  Valentina Svicher; Francesca Ceccherini-Silberstein; Mohammad Alkhatib; Romina Salpini; Luca Carioti; Francesca Alessandra Ambrosio; Stefano D'Anna; Leonardo Duca; Giosuè Costa; Maria Concetta Bellocchi; Lorenzo Piermatteo; Anna Artese; Maria Mercedes Santoro; Stefano Alcaro
Journal:  Microbiol Spectr       Date:  2022-03-30

Review 9.  Defining the risk of SARS-CoV-2 variants on immune protection.

Authors:  Marciela M DeGrace; Elodie Ghedin; Matthew B Frieman; Florian Krammer; Alba Grifoni; Arghavan Alisoltani; Galit Alter; Rama R Amara; Ralph S Baric; Dan H Barouch; Jesse D Bloom; Louis-Marie Bloyet; Gaston Bonenfant; Adrianus C M Boon; Eli A Boritz; Debbie L Bratt; Traci L Bricker; Liliana Brown; William J Buchser; Juan Manuel Carreño; Liel Cohen-Lavi; Tamarand L Darling; Meredith E Davis-Gardner; Bethany L Dearlove; Han Di; Meike Dittmann; Nicole A Doria-Rose; Daniel C Douek; Christian Drosten; Venkata-Viswanadh Edara; Ali Ellebedy; Thomas P Fabrizio; Guido Ferrari; Will M Fischer; William C Florence; Ron A M Fouchier; John Franks; Adolfo García-Sastre; Adam Godzik; Ana Silvia Gonzalez-Reiche; Aubree Gordon; Bart L Haagmans; Peter J Halfmann; David D Ho; Michael R Holbrook; Yaoxing Huang; Sarah L James; Lukasz Jaroszewski; Trushar Jeevan; Robert M Johnson; Terry C Jones; Astha Joshi; Yoshihiro Kawaoka; Lisa Kercher; Marion P G Koopmans; Bette Korber; Eilay Koren; Richard A Koup; Eric B LeGresley; Jacob E Lemieux; Mariel J Liebeskind; Zhuoming Liu; Brandi Livingston; James P Logue; Yang Luo; Adrian B McDermott; Margaret J McElrath; Victoria A Meliopoulos; Vineet D Menachery; David C Montefiori; Barbara Mühlemann; Vincent J Munster; Jenny E Munt; Manoj S Nair; Antonia Netzl; Anna M Niewiadomska; Sijy O'Dell; Andrew Pekosz; Stanley Perlman; Marjorie C Pontelli; Barry Rockx; Morgane Rolland; Paul W Rothlauf; Sinai Sacharen; Richard H Scheuermann; Stephen D Schmidt; Michael Schotsaert; Stacey Schultz-Cherry; Robert A Seder; Mayya Sedova; Alessandro Sette; Reed S Shabman; Xiaoying Shen; Pei-Yong Shi; Maulik Shukla; Viviana Simon; Spencer Stumpf; Nancy J Sullivan; Larissa B Thackray; James Theiler; Paul G Thomas; Sanja Trifkovic; Sina Türeli; Samuel A Turner; Maria A Vakaki; Harm van Bakel; Laura A VanBlargan; Leah R Vincent; Zachary S Wallace; Li Wang; Maple Wang; Pengfei Wang; Wei Wang; Scott C Weaver; Richard J Webby; Carol D Weiss; David E Wentworth; Stuart M Weston; Sean P J Whelan; Bradley M Whitener; Samuel H Wilks; Xuping Xie; Baoling Ying; Hyejin Yoon; Bin Zhou; Tomer Hertz; Derek J Smith; Michael S Diamond; Diane J Post; Mehul S Suthar
Journal:  Nature       Date:  2022-03-31       Impact factor: 69.504

10.  Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.

Authors:  Yang Liu; Jianying Liu; Bryan A Johnson; Hongjie Xia; Zhiqiang Ku; Craig Schindewolf; Steven G Widen; Zhiqiang An; Scott C Weaver; Vineet D Menachery; Xuping Xie; Pei-Yong Shi
Journal:  Cell Rep       Date:  2022-04-29       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.